Document
IPR2016-01129, No. 1162-244 Exhibit - EX1162 Dine Citizens Against Ruining Our Environment v US Office of Surface Mining Recl (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01129, No. 1162-244 Exhibit - EX1162 Dine Citizens Against Ruining Our Environment v US Office of Surface Mining Recl (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1077-123 Exhibit - Exhibit 1077 FDA News Release Xiidra (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1077-123 Exhibit - Exhibit 1077 FDA News Release Xiidra (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1050-96 Exhibit - Exhibit 1050 Allergan Release (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1050-96 Exhibit - Exhibit 1050 Allergan Release (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1095-141 Exhibit - Exhibit 1095 E Medicine Health What is Dry Eye Syndrome (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1095-141 Exhibit - Exhibit 1095 E Medicine Health What is Dry Eye Syndrome (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1032-83 Exhibit - Exhibit 1032 Orange Book 29th Eddition 2009 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1032-83 Exhibit - Exhibit 1032 Orange Book 29th Eddition 2009 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 3001-71 Exhibit - Exhibit 3001 (P.T.A.B. Mar. 31, 2017)
Cite Document
IPR2016-01129, No. 3001-71 Exhibit - Exhibit 3001 (P.T.A.B. Mar. 31, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2087-257 Exhibit - REDACTED Exhibit 2087 Patent License Agreement (P.T.A.B. Nov. 16, 2017)
Cite Document
IPR2016-01129, No. 2087-257 Exhibit - REDACTED Exhibit 2087 Patent License Agreement (P.T.A.B. Nov. 16, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1078-124 Exhibit - Exhibit 1078 Bailey Opt Times Shire (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1078-124 Exhibit - Exhibit 1078 Bailey Opt Times Shire (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2014-31 Exhibit - Lallemand et al, Cyclosporine a Delivery to the Eye A Pharmaceutical Challenge (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2014-31 Exhibit - Lallemand et al, Cyclosporine a Delivery to the Eye A Pharmaceutical Challenge (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2085-199 Exhibit - Assignment (P.T.A.B. Sep. 8, 2017)
Cite Document
IPR2016-01129, No. 2085-199 Exhibit - Assignment (P.T.A.B. Sep. 8, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2080-188 Exhibit - GraphPad Calculation of Bloch Table 2 3 mo B vs A (P.T.A.B. Jul. 14, 2017)
Cite Document
IPR2016-01129, No. 2080-188 Exhibit - GraphPad Calculation of Bloch Table 2 3 mo B vs A (P.T.A.B. Jul. 14, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1110-156 Exhibit - Exhibit 1110 Restasis commercial among most memorable ads of 2013 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1110-156 Exhibit - Exhibit 1110 Restasis commercial among most memorable ads of 2013 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2030-46 Exhibit - FDA Review, The Drug Development and Approval Process (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2030-46 Exhibit - FDA Review, The Drug Development and Approval Process (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 2016-33 Exhibit - Power et al, Effect of Topical Cyclosporin A on Conjunctival T Cells in Patients with Secondary Sj¿¿gren¿¿¿s Syndrome (P.T.A.B. Mar. 20, 2017)
Cite Document
IPR2016-01129, No. 2016-33 Exhibit - Power et al, Effect of Topical Cyclosporin A on Conjunctival T Cells in Patients with Secondary Sj¿¿gren¿¿¿s Syndrome (P.T.A.B. Mar. 20, 2017)
+ More Snippets
Document
IPR2016-01129, No. 1094-140 Exhibit - Exhibit 1094 Hessen et al NCBI DE Inflam Ocular Disease (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01129, No. 1094-140 Exhibit - Exhibit 1094 Hessen et al NCBI DE Inflam Ocular Disease (P.T.A.B. Jun. 30, 2017)
+ More Snippets